Cargando…

Metformin inhibits urothelial tumorigenesis in the UPII-mutant Ha-ras transgenic mouse model

Detalles Bibliográficos
Autores principales:	Liu, Zhongbo, Yokoyama, Noriko, Pollak, Michael, Zi, Xiaolin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073089/ http://dx.doi.org/10.1186/2049-3002-2-S1-P90

Ejemplares similares

Chemoprevention of Urothelial Cell Carcinoma Tumorigenesis by Dietary Flavokawain A in UPII-Mutant Ha-ras Transgenic Mice
por: Liu, Zhongbo, et al.
Publicado: (2022)

Kavalactone Kawain Impedes Urothelial Tumorigenesis in UPII-Mutant Ha-Ras Mice via Inhibition of mTOR Signaling and Alteration of Cancer Metabolism
por: Liu, Zhongbo, et al.
Publicado: (2023)

The Potent Anti-Tumor Effects of Rhodiola Drinking Are Associated with the Inhibition of the mTOR Pathway and Modification of Tumor Metabolism in the UPII-Mutant Ha-Ras Model
por: Liu, Zhongbo, et al.
Publicado: (2023)

Initial Evaluation of Uroplakins UPIIIa and UPII in Selected Benign Urological Diseases
por: Szymańska, Beata, et al.
Publicado: (2021)

Transgenic Rats Carrying Human c‐Ha‐ras Proto‐oncogene Are Highly Susceptible to N‐Nitrosomethylbenzylamine Induction of Esophageal Tumorigenesis
por: Asamoto, Makoto, et al.
Publicado: (2002)

Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model
por: Li, Xuesen, et al.
Publicado: (2015)

Ha-Ras/ERK1-2 pathway is responsible for oxygen species generation in scleroderma fibroblasts
por: Svegliati, S, et al.
Publicado: (2005)

Tauopathy-induced retinal dysfunction in the P301S mutant human tau transgenic mouse
por: Mazzaro, Nadia, et al.
Publicado: (2013)

Anti-tumor effect of a novel PI3-kinase inhibitor, SF1126, in (12) V-Ha-Ras transgenic mouse glioma model
por: Singh, Alok R, et al.
Publicado: (2014)

Transformation of NIH3T3 Cells with Synthetic c‐Ha‐ras Genes
por: Kamiya, Hiroyuki, et al.
Publicado: (1989)

Energy balance and cancer risk at the cellular and whole organism level: modification by metformin
por: Pollak, Michael
Publicado: (2012)

Site‐specific Mutation of the Human c‐Ha‐ras Transgene Induced by Dimethylbenzanthracene Causes Tissue‐specific Tumors in Mice
por: Doi, Satoru‐Takahiro, et al.
Publicado: (1994)

A high-fat diet increases the incidence of mammary cancer inc-Ha-ras proto-oncogene transgenic rats
por: Magaki, Mie, et al.
Publicado: (2016)

Dual mode of action of metformin on mitochondrial metabolism
por: Andrzejewski, Sylvia, et al.
Publicado: (2014)

Oxidative Stress Posttranslationally Regulates the Expression of Ha-Ras and Ki-Ras in Cultured Astrocytes
por: Messina, Samantha, et al.
Publicado: (2012)

Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing.
por: Yamamoto, S, et al.
Publicado: (1998)

Rare Activation of the Human c‐Ha‐ras Transgene of Mice in Hemangioendothelial Sarcomas and Liver Tumors Induced by Glu‐P‐1
por: Inoue, Rie, et al.
Publicado: (1996)

Kavalactone yangonin induces autophagy and sensitizes bladder cancer cells to flavokawain A and docetaxel via inhibition of the mTOR pathway
por: Liu, Zhongbo, et al.
Publicado: (2017)

Mammary Carcinomas Induced in Human c‐Ha‐ras Proto‐oncogene Transgenic Rats Are Estrogen‐independent, but Responsive to d‐Limonene Treatment
por: Asamoto, Makoto, et al.
Publicado: (2002)

Ha-ras restriction fragment length polymorphisms in colorectal cancer.
por: Wyllie, F. S., et al.
Publicado: (1988)

Transforming Activity of a Synthetic c‐Ha‐ras Gene Containing O(6)‐Methylguanine in Codon 12
por: Kamiya, Hiroyuki, et al.
Publicado: (1991)

Mechanism of skin tumorigenesis by contact sensitizers: the effect of the corticosteroid fluocinolone acetonide on inflammation and tumor induction by 2,4 dinitro-1-fluorobenzene in the skin of the TG.AC (v-Ha-ras) mouse.
por: Albert, R E, et al.
Publicado: (1996)

The Role of Steroid Hormone Receptors in Urothelial Tumorigenesis
por: Ide, Hiroki, et al.
Publicado: (2020)

Biokinetics and Subchronic Toxic Effects of Oral Arsenite, Arsenate, Monomethylarsonic Acid, and Dimethylarsinic Acid in v-Ha-ras Transgenic (Tg.AC) Mice
por: Xie, Yaxiong, et al.
Publicado: (2004)

C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro
por: Kusakari, T, et al.
Publicado: (2003)

Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer
por: Fernández Montes, A., et al.
Publicado: (2022)

Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts
por: Smaldone, Silvia, et al.
Publicado: (2011)

Metformin Therapy and Breast Cancer Incidence in the Ha’il Region
por: Osman, Mhdia, et al.
Publicado: (2023)

The Gain of Function of p53 Mutant p53S in Promoting Tumorigenesis by Cross-talking with H-RasV12
por: Jia, Shuting, et al.
Publicado: (2012)

Mutant Ras and inflammation-driven skin tumorigenesis is suppressed via a JNK-iASPP-AP1 axis
por: Al Moussawi, Khatoun, et al.
Publicado: (2022)

Sos-mediated cross activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis
por: Jeng, Hao-Hsuan, et al.
Publicado: (2012)

Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder
por: Oda, Shinsuke, et al.
Publicado: (2021)

Mutational analysis of Ras hotspots in patients with urothelial carcinoma of the bladder
por: Tripathi, Kiran, et al.
Publicado: (2020)

Cardiac diffusion tensor imaging: helix angle (HA) healthy statistical average technique for HA quantification in vivo
por: Ferreira, PF, et al.
Publicado: (2013)

Constitutional frequency of rare alleles of c-Ha-ras in breast cancer patients.
por: White, G. R., et al.
Publicado: (1988)

Ha-ras-1 restriction fragment length polymorphism and susceptibility to colon adenocarcinoma.
por: Ceccherini-Nelli, L., et al.
Publicado: (1987)

The Mutant Mouse Regional Resource Center Program
por: Lloyd, KCK
Publicado: (2003)

Expression of aquaporins in a transgenic mouse model of Alzheimer's disease
por: Chan, Sic L, et al.
Publicado: (2010)

Reversibility and progression in conditional transgenic mouse models of breast cancer
por: Chodosh, LA, et al.
Publicado: (2003)

Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
por: Schwall, RH, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_e0h5segk6o689cl3itmn67as1u